REYKJAVIK, Iceland, June 21 /PRNewswire-FirstCall/ -- deCODE genetics today announced that it will webcast live the presentations at the company’s annual R&D event being held in Reykjavik on Monday, June 26, 2006. deCODE management will present overviews of progress in the company’s drug development, drug discovery and genetics programs, as well as updates on finance, intellectual property and corporate alliances. The program will begin at 9am GMT/5am Eastern Time, and is expected to last approximately four hours.
The webcast can be accessed through the Investors page on deCODE’s website, www.decode.com. Those interested in listening should log on a few minutes in advance in order to download any software or complete any sign-in that may be required. The presentations will be archived on deCODE’s website.
About deCODE
deCODE is global leader in applying human genetics to develop drugs for common diseases. Our population approach has enabled us to discover and target key biological pathways involved in conditions ranging from heart attack to cancer. We are turning these discoveries into new medicine to better treat and prevent many of the biggest challenges to public health. deCODE is delivering on the promise of the new genetics.(SM) Visit us on the web at www.decode.com.
Contact: deCODE genetics Stefan Arnason +354 570 1995 ir@decode.is
deCODE genetics
CONTACT: Stefan Arnason, deCODE genetics, +354-570-1995, ir@decode.is
Web site: http://www.decode.com/
